Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » payor coverage

payor coverage

May 26, 2016

Cigna to Cover NanoString Prosigna Breast Cancer Test

The insurer is the latest to provide coverage for NanoString's gene expression-based breast cancer recurrence risk test.

May 11, 2016

Natera Says Bet on Average-Risk Pregnancies Paying Off as It Faces Changing Reimbursement Landscape

Premium

Natera said that a greater proportion of NIPTs for average-risk pregnancies are being reimbursed, while reimbursement for microdeletion testing is declining. 

May 10, 2016

NantHealth's Cancer Profiling Test Receives Coverage From Three Self-Insured Employers

Bank of America, Phoenix Children's Hospital, and Sanford Health said they would cover NantHealth's GPS Cancer test for some cancers. 

May 09, 2016

Aetna Issues Positive Coverage Decision for NanoString's Prosigna Breast Cancer Test

Aetna considers the test "medically necessary" and the decision opens the door for 19 million people to access the risk classifier test.

May 04, 2016

Sequenom Signs In-Network Contracts With Anthem Blue Cross, Blue Shield Plans

Sequenom has secured in-network status with seven state Anthem BCBS plans to provide NIPT to both high- and average-risk pregnancies.

Apr 08, 2016

Geisinger Health Plan Developing Coverage Policy for Diagnostic Exomes

The decision was made after Geisinger researchers and clinicians presented the health plan with evidence of the clinical utility of exome sequencing.

Mar 23, 2016

Sequenom Inks Deal With Anthem Blue Cross and Blue Shield for NIPT Test Coverage

The in-network contracts provide coverage for insured patients in Connecticut, Maine, and New Hampshire for both high- and average-risk pregnancies.

Feb 25, 2016

Anthem BCBS Georgia, Virginia to Cover Exact Sciences' Cologuard Test

Exact Sciences' CEO recently discussed the added coverage on a call with analysts to discuss Exact's Q4 earnings.

Feb 05, 2016

Cancer Genetics Signs Coverage Agreement With Blue Cross Blue Shield of Minnesota

The company said the agreement will make its cancer diagnostics and genomic tests available to more than 2.6 million people.

Jan 29, 2016

NantHealth Inks Coverage Deal for WGS, RNA-seq and Proteomic Test for Certain Cancer Indications

Premium

NantHealth is also planning to launch a 20,000-patient multi-arm, multi-drug trial based on profiling patients' tumors with its GPS Cancer test.

Pages

The Scan

Breathe It Out

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

The Next Batch

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Switch for the Second

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.

Science Reviews How Non-Genetic DNA Features Expand Utility of Liquid Biopsies, Presents Study of Enzymes in DNA Methylation

In Science this week: review discusses advances in liquid biopsies, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.